WRAIRWalter Reed Army Institute of Research
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Kayvon Modjarrad, director of WRAIR's Emerging Infectious Diseases Branch, the principal investigator of the study and first author on the publication, said, 'The world witnessed the emergence and devastation of SARS in 2002 and then MERS 10 years later.
In his research unit in a state prison, and at WRAIR, where he collaborated with two other prison facilities, he serendipitously discovered carnitine's role in cardiac disease in one of his prisoner volunteers.
While NIAID tests the VSV-ZEBOV vaccine candidate as a prime-boost strategy, WRAIR is evaluating the investigational vaccine as a single injection.
In order to rapidly proceed into Phase I clinical trials, the bulk vims manufactured by BioReiiance was formulated and lyophilized at the WRAIR Pilot Bioproduction facility and shipped to the adenovirus tableting facility for final dosage form manufacturing.
This studywas approved by Institutional Review Boards at the Walter Reed Army Institute of Research, Silver Spring, MD (WRAIR no.
He works at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, M.d.
The malaria vaccine is a story that goes back to 1987, when GSK Biologicals (the Belgium-based vaccine division of the global pharmaceutical giant, GSK--headquartered in London) in collaboration with the US Army's Walter Reed Army Institute of Research (WRAIR) developed RTS, S as a vaccine candidate.
The study was approved by the Kenya Medical Research Institute (KEMRI) Scientific Steering Committee, the KEMRI Ethics Review Committee, and the Walter Reed Army Institute of Research (WRAIR) Institutional Review Board.
Michael, director of MHRP and WRAIR's Division of Retrovirology.
The Walter Reed Army Institute of Research (WRAIR) is currently home to one of the nation's three pilot facilities dedicated to the production of a variety of investigational vaccines for use in clinical trials.
Outras instituicoes, como o Instituto Internacional de Vacinas (IVI) (20), sediado em Seul/ Coreia; o PATH (21), sediado em Seattle (EUA); The International Aids Vaccine Initiative (IAVI) (22), criada em 1996, com o objetivo principal de desenvolver uma vacina segura e eficaz contra Aids; e o Walter Reed Army Institute of Research (WRAIR) (23) vem desempenhando um papel importante na inovacao tecnologica de novas vacinas.
The Army tapped the Walter Reed Army Institute of Research (WRAIR) to develop mefloquine and it was later licensed to the Swiss pharmaceutical company F.